<p>Twenty years ago, 18-year-old Jesse Gelsinger died after taking part in a clinical trial for gene therapy at the University of Pennsylvania. The tragedy sent shock waves through Philadelphia’s biotech industry and across the medial world. Meir Rinde wrote about the case for the Science History Institute’s magazine Distillations and explains why Gelsinger’s death changed gene therapy.</p>

Twenty years ago, 18-year-old Jesse Gelsinger died after taking part in a clinical trial for gene therapy at the University of Pennsylvania. The tragedy sent shock waves through Philadelphia’s biotech industry and across the medial world. Meir Rinde wrote about the case for the Science History Institute’s magazine Distillations and explains why Gelsinger’s death changed gene therapy.

<p>Twenty years ago, 18-year-old&nbsp;Jesse Gelsinger died after taking part in a clinical trial for gene therapy at the University of Pennsylvania. The tragedy sent shock waves through Philadelphia’s biotech industry and across the medial world. Meir Rinde wrote about the case for the Science History Institute’s magazine Distillations and&nbsp;explains&nbsp;why Gelsinger’s death changed gene therapy.</p>

The Philadelphia tragedy that changed gene therapy

There’s more to every story, if you take the time to tell it. Get to the “why” behind the issues that matter in the Greater Philadelphia region with hosts Annette John-Hall and Shai Ben-Yaacov. Each episode, they’ll pluck one local story from your feed and break it down.

Share The Philadelphia tragedy that changed gene therapy

Sign up to save your podcasts

The Philadelphia tragedy that changed gene therapy

The Philadelphia tragedy that changed gene therapy

More shows like The Why: Philly Explained

Hidden Brain